KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 18 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $271,000 | +57.6% | 564,673 | +61.2% | 0.00% | – |
| Q1 2015 | $172,000 | -62.4% | 350,194 | +32.2% | 0.00% | -100.0% |
| Q4 2014 | $458,000 | +132.5% | 264,900 | +108.8% | 0.00% | 0.0% |
| Q3 2014 | $197,000 | -64.8% | 126,866 | -48.3% | 0.00% | 0.0% |
| Q2 2014 | $559,000 | +607.6% | 245,301 | +739.0% | 0.00% | – |
| Q1 2014 | $79,000 | -3.7% | 29,238 | +57.8% | 0.00% | – |
| Q4 2013 | $82,000 | – | 18,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,632,928 | $11,638,000 | 3.76% |
| Opaleye Management Inc. | 285,000 | $1,168,500,000 | 0.92% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,000 | $1,702,000 | 0.47% |
| Lehman Brothers Holdings Inc. | 657,442 | $2,906,000 | 0.28% |
| WALL STREET ASSOCIATES | 625,200 | $2,763,000 | 0.23% |
| Old West Investment Management, LLC | 56,925 | $251,000 | 0.15% |
| WEXFORD CAPITAL LP | 307,820 | $1,361,000 | 0.12% |
| CLOUGH CAPITAL PARTNERS L P | 397,400 | $1,757,000 | 0.06% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,699,975 | $20,774,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 80,650 | $356,000 | 0.02% |